BACKGROUND A few limited case series have shown that the subcutaneous implantable cardioverter-defibrillator (S-ICD) system is safe for teenagers and young adults, but a large-scale analysis currently is lacking. OBJECTIVES The purpose of this study was to compare mid-term device-associated outcomes in a large real-world cohort of S-ICD patients, stratified by age at implantation. METHODS Two propensity-matched cohorts of teenagers + young adults (≤30 years old) and adults (>30 years old) were retrieved from the ELISIR Registry. The primary outcome was the comparison of inappropriate shock rate. Complications, freedom from sustained ventricular arrhythmias, and overall and cardiovascular mortality were deemed secondary outcom...
BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibril...
Background. During the past decade. the implantable cardioverter-defibrillator (ICD) has emerged as ...
Objectives The aim of this study was to determine the efficacy of implantable cardioverter-defibrill...
Background: A few limited case series have shown that the S-ICD system is safe in teenagers and youn...
A few limited case series have shown that the subcutaneous implantable cardioverter-defibrillator (S...
Background: Implantable cardioverter defibrillators (ICD) are widely accepted therapy in children an...
Background: Young implantable cardioverter-defibrillator (ICD) patients are prone to complications a...
Background: Subcutaneous implantable cardioverter defibrillator (S-ICD) systems have no components ...
Background: Over the last several years the evolution of transvenous implantable cardioverter‑defibr...
Abstract. Objectives: This study examined the indicat-ions, efficacy and outcomes of implantable car...
BACKGROUND: The value of implantable cardioverter defibrillators (ICDs) in adults with congenital he...
Aims To investigate outcome and complications of implantable cardioverter defibrillators (ICDs) in a...
Background-The value of implantable cardioverter defibrillators (ICDs) in adults with congenital hea...
BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibril...
Background. During the past decade. the implantable cardioverter-defibrillator (ICD) has emerged as ...
Objectives The aim of this study was to determine the efficacy of implantable cardioverter-defibrill...
Background: A few limited case series have shown that the S-ICD system is safe in teenagers and youn...
A few limited case series have shown that the subcutaneous implantable cardioverter-defibrillator (S...
Background: Implantable cardioverter defibrillators (ICD) are widely accepted therapy in children an...
Background: Young implantable cardioverter-defibrillator (ICD) patients are prone to complications a...
Background: Subcutaneous implantable cardioverter defibrillator (S-ICD) systems have no components ...
Background: Over the last several years the evolution of transvenous implantable cardioverter‑defibr...
Abstract. Objectives: This study examined the indicat-ions, efficacy and outcomes of implantable car...
BACKGROUND: The value of implantable cardioverter defibrillators (ICDs) in adults with congenital he...
Aims To investigate outcome and complications of implantable cardioverter defibrillators (ICDs) in a...
Background-The value of implantable cardioverter defibrillators (ICDs) in adults with congenital hea...
BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibril...
Background. During the past decade. the implantable cardioverter-defibrillator (ICD) has emerged as ...
Objectives The aim of this study was to determine the efficacy of implantable cardioverter-defibrill...